Clinical Trials Browser

Phase 1 × OTHER × immunotoxin HA22 × Clear all

NCT00462189 2007-04-18

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell, Recurrence

NCT00457860 2007-04-17

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Recurrence